The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Concurrent durvalumab plus chemoradiation therapy followed by durvalumab in Chinese patients with unresectable stage III non-small cell lung cancer: CRUISER study.
 
Feifei Teng
No Relationships to Disclose
 
Hong Ge
No Relationships to Disclose
 
Buhai Wang
No Relationships to Disclose
 
Yaping Xu
No Relationships to Disclose
 
Xue Meng
No Relationships to Disclose
 
Suzhen Wang
No Relationships to Disclose
 
Ligang Xing
No Relationships to Disclose
 
Jinming Yu
No Relationships to Disclose